No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Xeljanz (tofacitinib) is a drug used to treat immune disorders, such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is a Janus kinase (JAK) inhibitor, which works by blocking certain proteins that are involved in the body's inflammatory response. Xeljanz is taken orally, usually twice daily, and is available in both tablet and suspension form. It is typically used in combination with other medications, such as methotrexate or biologic drugs.
Xeljanz is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2012. It has become a popular treatment option for immune disorders, due to its effectiveness and convenience.
Companies in the Xeljanz market include Pfizer, which manufactures and markets the drug, as well as other pharmaceutical companies that produce generic versions of the drug. Additionally, there are numerous companies that provide support services, such as patient assistance programs and educational materials. Show Less Read more
